Cocoon Capital

Cocoon Capital is a Singapore-based early-stage venture firm with a distinctive thesis: they back enterprise and B2B software companies in Southeast Asia, with a strong preference for founders building defensible, capital-efficient businesses in regulated and complex industries. The firm has a public reputation as a thoughtful, founder-friendly seed investor that takes meaningful board roles and supports founders through difficult product-market-fit phases. Healthcare exposure is selective but credible, with the fund’s pattern matching toward B2B health-tech, healthcare workflow, and enterprise software for clinics, hospitals, and payers in SEA markets. Stage focus is seed, with check sizes plausibly $250K to $1M and a willingness to lead in their domain. For healthcare AI founders, Cocoon is the right partner if you are a Southeast Asian B2B health-tech team — clinic software, hospital operations, payer ops, RCM, telehealth platforms — with a credible local team and revenue traction. Founders who should approach: SEA-based enterprise health-tech founders, particularly those building for the Singapore, Indonesia, Vietnam, and Philippines markets, who value a thesis-driven seed lead with strong governance and operating support. Founders who should not approach: consumer-only digital health, biotech, regulated medical devices needing specialist medtech syndicates, and US- or Europe-only companies. Cocoon’s value-add includes regional operator networks, downstream relationships with Series A funds active in SEA enterprise software, and a disciplined seed-stage governance approach. Entry path is warm introduction through their portfolio CEOs, the SEA enterprise-software founder community, or LinkedIn outreach to specific partners. Their LinkedIn and Crunchbase profiles list partners and portfolio.